🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

30+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 10 of 30 recruiting trials for “chronic-polyradiculoneuropathy”

Phase 3RecruitingNCT04929236 ↗

Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients

🏥 Octapharma📍 6 sites📅 Started Oct 2023View details ↗
RecruitingNCT06040567 ↗

Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study

👨‍⚕️ Britt S Pedersen, Rigshospitalet, University of Copenhagen📍 1 site📅 Started Sep 2023View details ↗
RecruitingNCT06183645 ↗

Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.

👨‍⚕️ Margaux Poleur, Dr, CHR Citadelle📍 1 site📅 Started Aug 2023View details ↗
Phase 2RecruitingNCT04881682 ↗

Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

👨‍⚕️ Johannes Dorst, Prof, University of Ulm📍 1 site📅 Started May 2023View details ↗
NARecruitingNCT05461898 ↗

RehabGBs: Rehabilitation in People With Guillain-Barré Syndrome

👨‍⚕️ Alda S Marques, PhD, School of Health Sciences, University of Aveiro (ESSUA)📍 1 site📅 Started Jan 2023View details ↗
Phase 2, PHASE3RecruitingNCT05327114 ↗

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

👨‍⚕️ Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC📍 103 sites📅 Started Sep 2022View details ↗
Phase 1RecruitingNCT05584631 ↗

IVIG vs SCIG in CIDP

👨‍⚕️ Luigi Brunetti, PhD, Rutgers, The State University of New Jersey📍 1 site📅 Started Sep 2022View details ↗
RecruitingNCT04672733 ↗

Hizentra® in Inflammatory Neuropathies - pHeNIx Study

👨‍⚕️ Study Director, CSL Behring SA📍 27 sites📅 Started Jun 2022View details ↗
Phase 4RecruitingNCT04589299 ↗

Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)

👨‍⚕️ Henning Andersen, MD,DMSc,PhD, Aarhus University, Aarhus University Hospital📍 4 sites📅 Started Jun 2020View details ↗
Phase 4RecruitingNCT03684018 ↗

Two Dose Levels of Privigen in Pediatric CIDP

👨‍⚕️ Study Director, CSL Behring📍 9 sites📅 Started Feb 2019View details ↗
← PreviousPage 2 of 2

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →